The clinical significance of hypogammaglobulinaemia and serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukaemia (CLL)

By Best Oliver G.   Crassini Kyle   Freeman Jane A.   Mulligan Stephen P.    

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 9, 2013-09 ,pp. : 729-729

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Intravenous Gammaglobulin for Immunoglobulin G Subclass and/or Antibody Deficiency in Adults

By  

International Archives of Allergy and Immunology, Vol. 149, Iss. 3, 2009-02 ,pp. : 267-274

Karger

Access to resources Recommend Favorite

Evaluation of Tumor Necrosis Factor-α and Erythropoietin Serum Levels in B-Cell Chronic Lymphocytic Leukemia Patients with Anemia

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : 967-969

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical activity of a new regimen combining gemcitabine and alemtuzumab in high‐risk relapsed/refractory chronic lymphocytic leukemia patients

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 1, 2015-01 ,pp. : 37-42

John Wiley & Sons Inc

Access to resources Recommend Favorite